查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370884

抗菌藥敏感性測試市場 - 2018-2028 年全球產業規模、佔有率、趨勢、競爭、機會和預測，按產品、技術、按應用、最終用戶、地區和競爭細分

Antimicrobial Susceptibility Testing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Technique, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

抗菌藥物敏感性測試 (AST) 是一種實驗室程序，用於確定細菌或真菌分離株對各種抗菌藥物的敏感性或抗藥性。體外抗菌藥物敏感性測試可以使用各種類型的形式進行，例如紙片擴散、瓊脂稀釋、肉湯微量稀釋、肉湯大量稀釋和濃度梯度測試。抗菌藥物敏感性測試 (AST) 的結果用於指導患者選擇適當的抗菌治療。藥敏結果以最低抑菌濃度（MIC）報告，這是抑制微生物生長的抗菌劑的最低濃度。可以使用 MIC 值來確定生物體是否對抗菌劑敏感、中間或抗藥性等幾個特徵。根據世界衛生組織（WHO）的報告，抗菌素抗藥性對全球健康構成重大威脅，預計到2050年，其造成的死亡人數將超過癌症。傳染患者病率的增加推動了抗菌藥物敏感性測試市場的發展。由於缺乏供水、環境衛生和個人衛生，志賀氏菌、淋病奈瑟菌、腦膜炎奈瑟氏菌和傷寒沙門氏菌等幾種傳染病的爆發，導致預測期內對抗菌藥敏感性測試的需求增加。此外，全國各地老年人口的增加以及某些類型的疾病流感、肺炎、帶狀皰疹和其他與老年相關的疾病預計將進一步推動全球抗菌藥物敏感性測試市場的成長預測期。

傳染病病率增加

傳染病是由細菌、病毒、真菌、寄生蟲和朊病毒等病原微生物引起的某些疾病。這些微生物可以侵入人體、繁殖並透過破壞組織、分泌毒素或引發導致發炎的免疫反應而引起疾​​病。流感、瘧疾、結核病、登革熱等是世界各地最常見的傳染病。抗菌藥物敏感性測試是確定傳染病適當抗菌治療的重要工具。當患者感染傳染病時，會採集細菌樣本並送往實驗室進行抗菌藥物敏感性測試。測試所獲得的結果用於指導選擇合適的抗生素來治療患者的感染。近年來，由 SARS-CoV-2 病毒引起的 COVID-19 大流行已成為影響世界各地許多人的主要傳染病。根據Worldometer 2023 年發布的報告，據觀察，2021 年，美國報告了約106,771,290 例COVID-19 病例，造成1,162,471 人死亡，其次是印度報告了44,971,469 例COVID-19 人死亡，其次是印度報告了44,971,469 例COVID-19 人死亡，造成 531,692949,6949 人死亡。法國的 COVID-19 病例導致 166,811 人死亡，等等。肺炎是全世界發展中國家流行的第二常見傳染病。根據聯合國兒童基金會 2019 年發布的報告，肺炎導致的兒童死亡人數超過任何其他傳染病，每年奪走超過 70 萬名五歲以下兒童的生命，即每天約 2,000 名兒童。其中包括超過 20 萬名新生兒。在全球範圍內，每年每100,000 名兒童中有1,400 多例肺炎病例，即每71 名兒童中有1 例，發病率最高的地區是南亞（每100,000 名兒童2,500 例）以及西非和中非（每100,000 名兒童1,620 例）。此外，人們對預防這些疾病的抗菌藥物敏感性測試的日益依賴，預計將在預測期內全球抗菌藥物敏感性測試市場中出現令人印象深刻的成長。

市場概況
預測期 2024-2028
2022 年市場規模 37.6億美元
2028 年市場規模 53.1億美元
2023-2028 年年複合成長率 5.91%
成長最快的細分市場 醫院
最大的市場 北美洲

老年人口成長

世界各地老年人口的成長也是預測期內全球抗菌藥物敏感性測試市場的重要促進因素之一。這是因為老年人更容易感染傳染病，而他們的免疫系統較弱，使他們更容易受到細菌感染。醫療保健和醫療技術的進步導致老年人的預期壽命更長，從而增加了他們對抗菌藥物敏感性測試的需求，以儘早阻止體內感染的發展。流感、帶狀皰疹、結核病、胃腸道感染和泌尿道感染是影響大多數 65 歲以後人群的疾病。根據人口資料局（PRB）根據世界上人口老化程度最高的國家發布的報告，得出的結論是，日本是世界上老齡化程度最高的國家，老年人口約佔總人口的28.2%，其次是日本。義大利的老年人口佔總人口的 22.8%，希臘和葡萄牙的老年人口佔總人口的 21.8%，德國的老年人口佔總人口的 21.4%。今後，全球各發展中國家老年人口比例的不斷上升以及與老年相關疾病的盛行率不斷上升，預計也將在未來幾年推動全球抗菌藥物敏感性測試市場的成長。

市場區隔

全球抗菌藥物敏感性測試市場根據產品、技術、應用、最終用戶、公司和地區進行細分。從產品來看，藥敏測試市場分為手動測試（MI​​C試紙、藥敏測試盤、藥敏板）、自動化儀器、耗材及介質。根據技術，全球抗菌藥物敏感性測試市場分為自動化 AST、Etest 方法、稀釋法、紙片擴散法等。在此基礎上，應用市場分為藥物開發、藥敏測試等。根據最終用戶，全球抗菌藥物敏感性測試市場分為醫院、診斷實驗室、生物技術和製藥公司等。

市場參與者

Bio-Rad Laboratories Inc.、Thermo Fisher Scientific Inc.、丹納赫公司、bioMerieux, Inc.、Creative Diagnostics、Hi-Media Laboratories Pvt. Ltd.、PerkinElmer, Inc.、ELITech Group SAS、F. Hoffmann-La Roche Ltd. 和 Accelerate Diagnostics, Inc. 是全球抗菌藥物敏感性測試市場的一些主要參與者。

報告範圍：

在本報告中，除了以下詳細介紹的產業趨勢外，全球抗菌藥物敏感性測試市場還分為以下幾類。

抗菌藥物敏感性測試市場，按產品：

  • 手動測試（MI​​C 試紙、藥敏測試盤、藥敏板）
  • 自動化儀器
  • 耗材和媒體

抗菌藥物敏感性測試市場（按技術）：

  • 自動化 AST
  • 測試方法
  • 稀釋
  • 圓盤擴散
  • 其他

抗菌藥物敏感性測試市場，按應用：

  • 藥物開發
  • 藥敏試驗
  • 其他

抗菌藥物敏感性測試市場，按最終用戶分類：

  • 醫院
  • 診斷實驗室
  • 生技與製藥公司
  • 其他

抗菌藥物敏感性測試市場，按地區：

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 亞太
  • 中國
  • 印度
  • 韓國
  • 澳洲
  • 日本
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 義大利
  • 南美洲
  • 巴西
  • 阿根廷
  • 哥倫比亞
  • 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

競爭格局

  • 公司簡介：全球抗菌藥物敏感性測試市場主要公司的詳細分析。

可用的客製化：

  • 根據給定的市場資料，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自訂選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球抗菌藥物敏感性測試市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 依產品（手動測試、（MIC 試紙條、磁敏測試盤、磁敏板）自動化儀器、耗材和介質）
    • 依技術（自動 AST、Etest 方法、稀釋、紙片擴散、其他）
    • 按應用（藥物開發、藥敏試驗、其他）
    • 按最終用戶（醫院、診斷實驗室、生物技術和製藥公司、其他）
    • 按地區
    • 按公司分類 (2022)
  • 產品市場地圖

第 6 章：北美抗菌藥物敏感性測試市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 依技術
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 7 章：歐洲抗菌藥物敏感性測試市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 依技術
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區抗菌藥物敏感性測試市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 依技術
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第 9 章：南美洲抗菌藥物敏感性測試市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 依技術
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲抗菌藥物敏感性測試市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 依技術
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非抗菌藥物敏感性測試
    • 沙烏地阿拉伯抗菌藥物敏感性測試
    • 阿拉伯聯合大公國抗菌藥物敏感性測試

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

第 13 章：大環境分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 公司概況
  • 產品與服務
  • 財務（上市公司）
  • 最近的發展
  • SWOT分析
    • Bio-Rad Laboratories Inc.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • bioMerieux, Inc.
    • Creative Diagnostics
    • Hi-Media Laboratories Pvt. Ltd.
    • PerkinElmer, Inc.
    • ELITech Group SAS
    • F. Hoffmann-La Roche Ltd.
    • Accelerate Diagnostics, Inc.

第 16 章：策略建議

第 17 章：關於我們與免責聲明

簡介目錄
Product Code: 15570

Antimicrobial susceptibility testing (AST) is a laboratory procedure used to determine the susceptibility or resistance of a bacterial or fungal isolate to various antimicrobial agents. In-vitro antimicrobial susceptibility testing can be performed using various type of formats such as disk diffusion, agar dilution, broth microdilution, broth macrodilution, and a concentration gradient test. The results of Antimicrobial Susceptibility Testing (AST) are used to guide the choice of appropriate antimicrobial therapy for the patient. Susceptibility results are reported as the minimum inhibitory concentration (MIC), which is the lowest concentration of the antimicrobial agent that inhibits the growth of the organism. Several characteristics such as whether the organism is susceptible, intermediate, or resistant to the antimicrobial agent can be determined using MIC values. According to a report by the World Health Organization (WHO), antimicrobial resistance is a significant threat to global health, and it is estimated that by 2050, it could cause more deaths than cancer. The market for antimicrobial susceptibility testing is driven by the increase in prevalence of infectious diseases. Several infectious disease outbreaks such as Shigella, Neisseria gonorrhoeae, Neisseria meningitides, and Salmonella serotype typhi which has been attributed to lack of water supply, sanitation, and hygiene are rising the demand for antimicrobial susceptibility testing in the forecast period. Moreover, increase in geriatric population across various parts of the country along with certain type of diseases influenza, pneumonia, shingles, and others which are associated with them in their elder age is further expected to propel the growth of global antimicrobial susceptibility testing market in the forecast period.

Increase in Prevalence of Infectious Diseases

Infectious diseases are certain kind of disorders caused by pathogenic microorganisms, such as bacteria, viruses, fungi, parasites, and prions. These microorganisms can invade the human body, multiply, and cause disease by damaging tissues, secreting toxins, or triggering an immune response that results in inflammation. Influenza, malaria, tuberculosis, dengue, and others are some of the most commonly prevailing infectious diseases across the world. Antimicrobial susceptibility testing is a critical tool for determining the appropriate antimicrobial therapy for infectious diseases. When a patient gets affected with infectious disease, sample of the bacteria is taken and is sent to the laboratory for antimicrobial susceptibility testing. Results obtained from the test are used to guide the selection of an appropriate antibiotic for treating the patient's infection. In recent times, COVID-19 pandemic caused by the SARS-CoV-2 virus have emerged as the leading infectious disease affecting many people across the world. According to the report published by Worldometer in 2023, it has been observed that in 2021 around 106,771,290 cases of COVID-19 were reported in United States of America causing 1,162,471 deaths, followed by 44,971,469 cases of COVID-19 in India causing 531,692 deaths, 40,021,949 cases of COVID-19 in France leading to 166,811 deaths, and so on. Pneumonia is the second most common infectious diseases prevailing in various developing countries across the world. As per the report presented by UNICEF in 2019, it has been concluded that pneumonia kills more children than any other infectious disease, claiming the lives of over 700,000 children under five every year, or around 2,000 every day. This includes over 200,000 newborns. Globally, there are over 1,400 cases of pneumonia per 100,000 children, or 1 case per 71 children every year, with the greatest incidence occurring in South Asia (2,500 cases per 100,000 children) and West and Central Africa (1,620 cases per 100,000 children). Moreover, growing dependence of people on antimicrobial susceptibility testing for prevention of these diseases is further expected to register an impressive growth to global antimicrobial susceptibility testing market in the forecast period.

Market Overview
Forecast Period2024-2028
Market Size 2022USD3.76 Billion
Market Size 2028USD5.31 Billion
CAGR 2023-20285.91%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Growth in Geriatric Population

Growth in geriatric population across various parts of the world is also one of the significant drivers of global antimicrobial susceptibility testing market in the forecast period. This is because the elderly population is more vulnerable to infectious diseases, and their weakened immune systems make them more susceptible to bacterial infections. Improvement in healthcare and medical technology have led to longer life expectancies among geriatric people which is thereby growing the demand of antimicrobial susceptibility testing among them to stop the development of infection in their body at early stage. Influenza, shingles, tuberculosis, gastrointestinal infections, and urinary tract infections are some of the diseases which effects most of the people after 65 years of age. According to the report published by Population Reference Bureau (PRB) based on countries with the oldest populations in the world, it has been concluded that Japan is the foremost country in the world accounting for around 28.2% of geriatric people out of total population, followed by Italy with 22.8% of geriatric population, Greece, and Portugal with 21.8 %, and Germany with 21.4% of geriatric people out of the total population. Henceforth, growing ratio of geriatric population in various developing countries across the globe and growing prevalence of diseases associated with people during their elder age is also expected to bolster the growth of global antimicrobial susceptibility testing market in upcoming years.

Market Segmentation

The global antimicrobial susceptibility testing market is segmented based on product, technique, application, end user, company, and region. In terms of product, the antimicrobial susceptibility testing market is categorized into manual tests, (MIC strips, susceptibility testing disks, susceptibility plates), automated instruments, and consumables & media. Based on technique, global antimicrobial susceptibility testing market is fragmented into automated AST, Etest method, dilution, disk diffusion, and others. Based on, application market is segmented into drug development, susceptibility testing, and others. Based on end user, global antimicrobial susceptibility testing market is fragmented into hospitals, diagnostic laboratories, biotechnique & pharmaceutical companies, and others.

Market Players

Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, bioMerieux, Inc., Creative Diagnostics, Hi-Media Laboratories Pvt. Ltd., PerkinElmer, Inc., ELITech Group SAS, F. Hoffmann-La Roche Ltd., and Accelerate Diagnostics, Inc. are some of the key players in the global antimicrobial susceptibility testing market.

Report Scope:

In this report, global antimicrobial susceptibility testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below.

Antimicrobial Susceptibility Testing Market, By Product:

  • Manual Tests (MIC Strips, Susceptibility Testing Disks, Susceptibility Plates)
  • Automated Instruments
  • Consumables & Media

Antimicrobial Susceptibility Testing Market, By Technique:

  • Automated AST
  • Etest Method
  • Dilution
  • Disk Diffusion
  • Others

Antimicrobial Susceptibility Testing Market, By Application:

  • Drug Development
  • Susceptibility Testing
  • Others

Antimicrobial Susceptibility Testing Market, By End User:

  • Hospitals
  • Diagnostic Laboratories
  • BioTechnique & Pharmaceutical Companies
  • Others

Antimicrobial Susceptibility Testing Market, By region:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in global antimicrobial susceptibility testing market.

Available Customizations:

  • With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Antimicrobial Susceptibility Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Manual Tests, (MIC Strips, Susceptibility Testing Disks, Susceptibility Plates) Automated Instruments, Consumables & Media)
    • 5.2.2. By Technique (Automated AST, Etest Method, Dilution, Disk Diffusion, Others)
    • 5.2.3. By Application (Drug Development, Susceptibility Testing, Others)
    • 5.2.4. By End User (Hospitals, Diagnostic Laboratories, BioTechnique & Pharmaceutical Companies, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Product Market Map

6. North America Antimicrobial Susceptibility Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technique
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Antimicrobial Susceptibility Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value & Volume
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Mexico Antimicrobial Susceptibility Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value & Volume
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Canada Antimicrobial Susceptibility Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value & Volume
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Antimicrobial Susceptibility Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technique
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3 Europe: Country Analysis
    • 7.3.1. France Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Germany Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia-Pacific Antimicrobial Susceptibility Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technique
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. South Korea Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Japan Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value & Volume
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value & Volume
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. South America Antimicrobial Susceptibility Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technique
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Antimicrobial Susceptibility Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Antimicrobial Susceptibility Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Antimicrobial Susceptibility Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Middle East and Africa Antimicrobial Susceptibility Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technique
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Antimicrobial Susceptibility Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Antimicrobial Susceptibility Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Antimicrobial Susceptibility Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Company Snapshot
  • 15.3. Products & Services
  • 15.4. Financials (In case of listed companies)
  • 15.5. Recent Developments
  • 15.6. SWOT Analysis
    • 15.6.1. Bio-Rad Laboratories Inc.
    • 15.6.2. Thermo Fisher Scientific Inc.
    • 15.6.3. Danaher Corporation
    • 15.6.4. bioMerieux, Inc.
    • 15.6.5. Creative Diagnostics
    • 15.6.6. Hi-Media Laboratories Pvt. Ltd.
    • 15.6.7. PerkinElmer, Inc.
    • 15.6.8. ELITech Group SAS
    • 15.6.9. F. Hoffmann-La Roche Ltd.
    • 15.6.10. Accelerate Diagnostics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer